Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Profit After Tax (2020 - 2025)

Historic Profit After Tax for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to -$10.9 million.

  • Insight Molecular Diagnostics' Profit After Tax rose 1955.83% to -$10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$60.8 million, marking a year-over-year decrease of 4087.24%. This contributed to the annual value of -$60.7 million for FY2024, which is 11836.15% down from last year.
  • Insight Molecular Diagnostics' Profit After Tax amounted to -$10.9 million in Q3 2025, which was up 1955.83% from -$9.7 million recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Profit After Tax ranged from a high of $6.0 million in Q1 2023 and a low of -$45.0 million during Q4 2022
  • For the 5-year period, Insight Molecular Diagnostics' Profit After Tax averaged around -$13.1 million, with its median value being -$9.7 million (2025).
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Profit After Tax tumbled by 46879.06% in 2021, and later surged by 15790.5% in 2023.
  • Quarter analysis of 5 years shows Insight Molecular Diagnostics' Profit After Tax stood at -$35.9 million in 2021, then fell by 25.34% to -$45.0 million in 2022, then skyrocketed by 64.44% to -$16.0 million in 2023, then crashed by 109.55% to -$33.5 million in 2024, then surged by 67.61% to -$10.9 million in 2025.
  • Its Profit After Tax was -$10.9 million in Q3 2025, compared to -$9.7 million in Q2 2025 and -$6.7 million in Q1 2025.